Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$0.3 - $0.46 $2,490 - $3,818
8,300 Added 0.25%
3,293,382 $1.15 Million
Q3 2023

Nov 09, 2023

BUY
$0.4 - $1.1 $303,601 - $834,904
759,004 Added 30.05%
3,285,082 $1.54 Million
Q2 2023

Aug 07, 2023

BUY
$0.66 - $1.15 $355,972 - $620,255
539,353 Added 27.15%
2,526,078 $2.78 Million
Q1 2023

May 04, 2023

BUY
$1.05 - $1.61 $222,311 - $340,877
211,725 Added 11.93%
1,986,725 $2.36 Million
Q4 2022

May 23, 2023

SELL
$1.27 - $1.84 $268,890 - $389,574
-211,725 Reduced 10.66%
1,775,000 $2.64 Million
Q4 2022

Feb 13, 2023

BUY
$1.27 - $1.84 $2.25 Million - $3.27 Million
1,775,000 New
1,775,000 $2.65 Million

Others Institutions Holding SCTL

About SOCIETAL CDMO INC COM


  • Ticker SCTL
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,657,900
More about SCTL
Track This Portfolio

Track Royce & Associates LP Portfolio

Follow Royce & Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.